Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinical trials couldn’t have come at a better time.

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

AUGUST 10, 2021

Enters into the Chronic Pain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. Global Wellness Strategies Inc. ( billion in 2030.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. Chief Scientific Officer. MyMD Pharmaceuticals, Inc.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. We look forward to providing continuing updates as we advance this drug candidate in the clinic.”.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Project CBD

FEBRUARY 27, 2023

But there’s another option that can address mood, pain, and more at once, all with fewer side effects: cannabis. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” It’s not a new idea.

THC 144

THC CBD Sleep Clinical Trials 144

Healer

MARCH 26, 2021

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

NORML

JANUARY 28, 2019

It’s understandable lawmakers want reliable data before making a decision. The good news for Kentucky legislators is the data already i s available. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine.

Data 187

Data Clinical Trials Chronic Pain Medicine 187

Cannabis Law Report

JUNE 7, 2022

On the contrary, researchers are leaning more towards CBD as a beneficial chemical with therapeutic effects on various physical and mental health problems, from anxiety to chronic pain. Relieves Chronic Pain. Other studies found encouraging results on neuropathic pain, arthritis pain, and multiple sclerosis.

Chronic Pain 52

Chronic Pain CBD Digestion Edibles 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. Pain, anxiety and sleep issues are often interconnected – chronic pain can also cause mental health and sleep issues.”. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

The Joint Blog

FEBRUARY 11, 2022

The data from this study is promising and reveals that CBD worked to inhibit the spread of a virus in human lung cell samples, which is huge news. However, it warrants further examination and exploration by science in the form of clinical trials, which is what many in the scientific community are calling for.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Veriheal

MAY 3, 2022

The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. The team focused its efforts on understanding whether owning an MMJ card impacted CUD, particularly in terms of chronic pain, insomnia, anxiety, or depressive symptoms.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Project CBD

MAY 3, 2023

She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. But we may be on the cusp of having those trials, which would be very exciting.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

SEPTEMBER 14, 2021

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Canna Care Docs

DECEMBER 16, 2020

Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain. Next to chronic pain, treatment for multiple sclerosis is the second most common reason people seek medical marijuana in the US. Research is ongoing, but the existing data and anecdotal reports show potential.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Veriheal

JULY 12, 2021

According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. A 2020 study reported that the top conditions reported amongst veterans include chronic pain , sleep problems , anxiety , and depression.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Cannabis Law Report

OCTOBER 6, 2021

With the additional funding recently secured by Virpax and the strengthening of our balance sheet, we are continuing to advance our product candidates and to move them through preclinical studies and into human clinical trials,” said Anthony Mack, Chairman and Chief Executive Officer of Virpax Pharmaceuticals.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

NOVEMBER 16, 2021

Believed to be the only IND application ever cleared by the FDA for a Phase 2 trial of a patented drug for delaying aging. Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. In October 2021, Virpax announced that a $1.87 About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

OCTOBER 26, 2021

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. 1 Data published by Research and Markets, March 2018. Dr. Chapman Bio. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

MAY 14, 2022

Canpain is planned to run for three years and aims to conduct clinical trials involving up to 5,000 patients suffering from chronic pain. The trial will be the first of its kind in the UK and could be significant in opening access to CBPMs for the UK’s estimated 1.4

Access 52

Access CBD Research and Development Medicine 52

Puff Puff Post

JANUARY 1, 2020

Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain. Acceptance of Medicinal Cannabis.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Weedistry

JANUARY 28, 2019

The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

The Herb Collective

JUNE 3, 2018

Treats Chronic Pain Patients suffering from chronic pain have reported that CBD oil acts as a soothing agent. The product also stabilizes blood sugar levels, prevents inflammation in nerves, relieves muscle cramps and gastrointestinal pains, lowers blood pressure, helps diabetics with restless leg syndrome (RLS).

Oil 56

Oil CBD Blood Pressure Chronic Pain 56

Puff Puff Post

JANUARY 1, 2020

Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain. Acceptance of Medicinal Cannabis.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Veriheal

AUGUST 31, 2020

Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

MMJ Recs

JUNE 15, 2022

Some of the best pain management doctors in NYC are found at the Ainsworth Institute. Their website is a fount of information that indicates high patient satisfaction (including testimonials and data on clinical trials).

Patients 52

Patients Treatment Clinical Trials Therapy 52

CannaTech

SEPTEMBER 16, 2018

But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression. This knowledge gap isn’t surprising, as cannabis as a medicine is non-traditional in its very nature.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

OCTOBER 1, 2021

Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta™ is an intranasal molecular-envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. About Channelchek. Channelchek (.com)

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

JANUARY 13, 2023

A review of existing endocannabinoid system and migraine research from March 2022 identified many surveys, but fewer clinical research trials, and even fewer double-blind placebo studies. 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

The Joint Blog

APRIL 17, 2020

Crohn’s ), chronic pain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more. While there have been significant studies done over the years, only chronic pain, antiemesis, multiple sclerosis , and sleep have any level of evidence of cannabis effectiveness.

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

MAY 13, 2019

“There’s still a lot we don’t know about medicinal cannabis … when it comes to the pharmacology, what does it do on a molecular level and how does it affect things like chronic pain or symptoms of MS [multiple sclerosis]?”. Data Availability: All relevant data are within the paper and its Supporting Information files.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Puff Puff Post

SEPTEMBER 16, 2019

The clinical care team is comprised of family physicians and specialists in chronic pain , cancer, gastroenterology, and endocrinology, as well as nurses with clinical expertise in cannabis medicine. ABOUT SPECTRUM THERAPEUTICS.

Programs 108

Programs Research and Development Education Treatment 108